NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs062240076

Registered date:06/11/2024

A study on the efficacy and safety of a new bone-anchored hearing aid (Osia system)

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedconductive or mixed hearing loss
Date of first enrollment06/11/2024
Target sample size4
Countries of recruitment
Study typeInterventional
Intervention(s)Implantation of Osia system. The Osia system consists of an implant part (OSI200), a bone conduction terminal (BI300), and a sound processor (Osia2 sound processor). A sound processor collect sounds and send it to the OSI20 0 implant via a digital induction link. The OSI200 implant receives the signal and converts it into vibr ations. The bone conductive terminal fixed to the OSI200 implant is screwed into the bone and osse ointegrated, and its vibrations are transmitted thro ugh the bone to the inner ear, stimulating the audi tory nerve. The implant is used permanently.

Outcome(s)

Primary OutcomeComparison between the average of hearing thres hold under wearing sound processor 3 months aft er surgery and the average of preoperative hearing threshold.
Secondary OutcomeComparison of the following hearing results 3 and 6 months after surgery with preoperative hearing r esults -The threshold for each frequency -Speech perception test in quiet (iCI-2004) -Speech perception test in noise (iCI-2004) -subjective evaluation by questionnaire (SSQ and HHI) Surgical information Adverse events due to surgery or Osia system

Key inclusion & exclusion criteria

Age minimum>= 5age old
Age maximumNot applicable
GenderBoth
Include criteriaCases of unilateral or bilateral conductive/mixed hearing loss The average of conduction hearing level on the im planted side less than 55dB Age more than 5, and body weight more than 7kg The thickness of the bone at the implantation site more than 3mm Cases who have experience wearing optimally adj usted hearing aids Cases whose native language is Japanese Informed consent can be obtained
Exclude criteriaCases whose bone quality/volume at the implantation site is expected to be insufficient to support the implant (BI300) Cases with chronic or irreversible vestibular or bal ance disorder Cases with severe progressive hearing loss Cases with bilateral retro-cochlear or central heari ng loss Skin condition is inadequate for wearing the soun d processor Sugery is expected to be difficult due to complications Cases judge to be inappropriate for participation in the clinical study by the physician

Related Information

Contact

Public contact
Name Masato Teraoka
Address 454 Shitsukawa, Toon, Ehime, Japan Ehime Japan 791-0295
Telephone +81-89-960-5366
E-mail mteraoka@m.ehime-u.ac.jp
Affiliation Ehime University Hospital
Scientific contact
Name Naohito Hato
Address 454 Shitsukawa, Toon, Ehime, Japan Ehime Japan 791-0295
Telephone +81-89-960-5366
E-mail nhato@m.ehime-u.ac.jp
Affiliation Ehime University Hospital